Kaplan-Meier assessment demonstrated that HCC patients with low BMAL1 expression level exhibited remarkably poor overall survival (OS) and relapse-free survival (RFS) compared with those with high BMAL1 expression (Figure 1H). Here, BMAL1 is linked to hepatocellular carcinoma.